• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Litmus Health Unveils Free Version of Data Science Platform for Academic Researchers

by HITC Staff 04/13/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Litmus Health Unveils Free Version of Data Science Platform for Academic Researchers

Litmus Health, a clinical data science platform focused on health-related quality of life has released a free version of its data science platform for academic researchers running trials and studies. With Litmus Free, researchers gain access to modern tools for running data-driven clinical trials. 

Imagine if every academic institution had a modern EDC and the ability to collect patient data from the point of experience. Litmus Free is their opportunity to shift budget and resources from the manual labor of data management to actual research. The Litmus platform supports more than 200 data sources that describe patients’ behavior and environments. The platform also includes a library of freely-validated patient surveys. Novel data sources and premium royalty-based instruments can be added for a fee.

Litmus is configured to match each study’s unique protocol’s design, combining traditional validated surveys with patient-generated remote data streams. The result is a comprehensive indication of a patient’s health and quality of life at any point in time.

Academic studies and trials often run at smaller scales, but still generate enough data to make manual patient data collection and management efforts cumbersome. Competing offerings are usually too expensive for academic research, or consume a disproportionate percentage of grant monies.

“The Litmus team traces its roots to academia. We’re researchers at heart,” said Dr. Sam Volchenboum, co-founder and Chief Medical Officer of Litmus Health. “We’ve seen firsthand the value that this kind of technology can have on trials of any size, and how that can transform research and outcomes from the earliest stages.”

Once data are collected, academic researchers use Litmus’ Study Hub to track each study’s progress and surface population-wide trends. Researchers can also view individual progress and adherence, as well as download bulk data for later analysis.

New research under the Litmus Free program will be on-boarded to the platform starting June 1. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: clinical data science, Clinical Trial, Litmus Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |